CDC7 as a novel biomarker and druggable target in cancer
Clin. transl. oncol. (Print)
; 24(10): 18561864, octubre 2022.
Artigo
em Inglês
| IBECS
| ID: ibc-207942
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Due to the bottlenecks encountered in traditional treatment for tumor, more effective drug targets need to be developed. Cell division cycle 7 kinase plays an important role in DNA replication, DNA repair and recombination signaling pathways. In this review, we first describe recent studies on the role of CDC7 in DNA replication in normal human tissues, and then we integrate new evidence focusing on the important role of CDC7 in replication stress tolerance of tumor cells and its impact on the prognosis of clinical oncology patients. Finally, we comb through the CDC7 inhibitors identified in recent studies as a reference for further research in clinical practice. (AU)
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
DNA
/
Biomarcadores
/
Proteínas Serina-Treonina Quinases
/
Proteínas de Ciclo Celular
Limite:
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Guangxi Medical University/China